| Literature DB >> 33578565 |
Chun Chen1, Xiaolin Cheng, Lei Lin, Fangfang Fu.
Abstract
ABSTRACT: Preoperative anxiety is a major problem in children leading to a poor outcome. Preanesthetic oral ketamine is generally used in children but has less bioavailability due to the first-pass effect. Even ketamine has an unpleasant taste. Preanesthetic inhaled ketamine is also reported effective and safe in children. The objectives of the study were to compare the effectiveness and safety of preanesthetic nebulized ketamine against preanesthetic oral ketamine for sedation and postoperative pain management in children.Children received 10 mg/kg oral ketamine (children received preanesthetic oral ketamine [OK cohort], n = 142), or nebulized with 3 mg/kg ketamine (children were preanesthetic nebulized with ketamine [NK cohort], n = 115), or received apple juice (children suspectable to preoperative ketamine and received apple juice only [OA cohort], n = 126) before anesthesia for elective surgery. Data regarding preoperative hemodynamic parameters, sedation score measurements, postoperative pain management, postoperative nausea and vomiting management, and postoperative complications were collected and analyzed.Preoperative hemodynamic parameters for oral and nebulized ketamine administration were stable. Nebulized ketamine was provided higher sedation than apple juice (P = .002, q = 4.859) and oral ketamine (P = .002, q = 3.526). Children of NK cohort had required fewer fentanyl consumption until discharge than those of OA (55.45 ± 7.19 μG/ child vs 65.15 ± 15.24 μG/ child, P < .0001, q = 9.859) and OK (55.45 ± 7.19 μG/child vs 60.19 ± 8.12 μG/child, P < .0001, q = 4.953) cohorts. Children of the NK cohort had consumed higher ondansetron syrup than those of the OA cohort but fewer than those of the OK cohort until discharge. Gastrointestinal side effects were reported in the OK cohort, and nose irritation and drowsiness were reported in the NK cohort.Like preanesthetic oral ketamine, preanesthetic inhaled ketamine also has safety for children. Preanesthetic inhaled ketamine can provide effective sedation in low doses during operation than preanesthetic oral ketamine.Level of evidence: III.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33578565 PMCID: PMC7886447 DOI: 10.1097/MD.0000000000024605
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Flow diagram of the study.
Preoperative and operative clinical conditions of children enrolled in the study.
| Cohorts | |||||
| Characteristics | OA | OK | NK | ||
| Preanesthetic interventions | Total | Apple juice | Oral ketamine | Nebulized ketamine | Comparison between cohorts |
| Numbers of children | 383 | 126 | 142 | 115 | |
| Age (yrs) | |||||
| Minimum | 3 | 4 | 3 | 3 | .061 |
| Maximum | 10 | 8 | 9 | 10 | |
| Mean ± SD | 4.15 ± 1.17 | 3.95 ± 1.61 | 4.21 ± 1.11 | 4.41 ± 1.79 | |
| Body mass index (kg/m2) | |||||
| Minimum | 16.51 | 16.51 | 17.09 | 16.88 | .055 |
| Maximum | 20.32 | 20.22 | 19.89 | 20.32 | |
| Mean ± SD | 17.18 ± 1.65 | 16.85 ± 2.01 | 17.39 ± 1.72 | 17.81 ± 1.82 | |
| Gender | |||||
| Male | 219 (57) | 71 (56) | 81 (57) | 67 (58) | .955 |
| Female | 164 (43) | 55 (44) | 61 (43) | 48 (42) | |
| American Society of Anesthesiologists status | |||||
| I | 298 (78) | 91 (72) | 115 (81) | 92 (80) | .181 |
| II | 85 (22) | 35 (28) | 27 (19) | 23 (20) | |
| Ethnicity | |||||
| Han Chinese | 353 (92) | 116 (92) | 131 (92) | 106 (92) | .986 |
| Mongolian | 26 (7) | 9 (7) | 9 (7) | 8 (7) | |
| Tibetan | 4 (1) | 1 (1) | 2 (1) | 1 (1) | |
| Elective Surgeries | |||||
| Correction of bone fractures | 222 (58) | 73 (58) | 78 (55) | 71 (62) | .074 |
| Congenital cardiac defects | 84 (22) | 29 (23) | 40 (28) | 15 (13) | |
| Abdominal wall defects | 61 (16) | 21 (17) | 19 (13) | 21 (18) | |
| Appendicitis | 16 (4) | 3 (2) | 5 (4) | 8 (7) | |
| Duration of surgery (min) | 76.22 ± 8.23 | 71.85 ± 15.16 | 75.21 ± 9.89 | 77.01 ± 25.12 | .064 |
Constant data are demonstrated as frequency (percentages) and continuous data are demonstrated mean ± standard deviation.
One-way analysis of variance for continuous data and the Fischer exact test for constant data were performed for statistical analysis.
A P < .05 was considered as significant.
Preoperative hemodynamic parameters.
| Cohorts | ||||
| Parameters | OA | OK | NK | |
| Pre-anesthetic interventions | Apple juice | Oral ketamine | Nebulized ketamine | Comparison between cohorts |
| Numbers of children | 126 | 142 | 115 | |
| Heart rate | ||||
| Baseline | 113.15 ± 15.14 | 111.21 ± 12.15 | 109.14 ± 16.18 | .100 |
| 5 min after administration | 106.85 ± 14.13 | 104.23 ± 9.42 | 102.92 ± 15.12 | .055 |
| 30 min after administration | 89.22 ± 14.12 | 87.15 ± 12.85 | 85.61 ± 11.14 | .090 |
| Mean arterial blood pressure | ||||
| Baseline | 70.12 ± 5.21 | 71.21 ± 4.56 | 71.98 ± 7.99 | .053 |
| 5 min after administration | 69.15 ± 4.98 | 70.55 ± 4.12 | 70.51 ± 6.55 | .053 |
| 30 min after administration | 68.54 ± 4.55 | 68.52 ± 3.53 | 67.29 ± 5.53 | .051 |
| Respiratory rate (breath/min) | ||||
| Baseline | 29.21 ± 3.98 | 29.01 ± 4.01 | 29.12 ± 3.95 | .919 |
| 5 min after administration | 28.22 ± 4.23 | 27.95 ± 3.53 | 28.12 ± 4.56 | .861 |
| 30 min after administration | 27.58 ± 3.52 | 26.52 ± 4.55 | 26.58 ± 3.55 | .056 |
| Peripheral capillary oxygen saturation | ||||
| Baseline | 98.43 ± 1.42 | 98.53 ± 1.11 | 98.63 ± 1.52 | .516 |
| 5 min after administration | 98.08 ± 2.01 | 97.62 ± 1.69 | 97.59 ± 1.61 | .051 |
| 30 min after administration | 98.01 ± 0.90 | 97.61 ± 2.43 | 97.53 ± 1.98 | .105 |
Data are demonstrated as mean ± standard deviation.
Baseline: On admission in the preoperative room.
One-way analysis of variance was performed for statistical analysis.
A P < .05 was considered as significant.
After administration: After administration of ketamine or apple juice.
Preoperative sedation score measurements of children after intervention and before operation.
| Cohorts | Comparison between cohorts | ||||||
| Sedation score | OA | OK | NK | ||||
| Preanesthetic interventions | Apple juice | Oral ketamine | Nebulized ketamine | ||||
| Numbers of children | 126 | 142 | 115 | Between OA and OK | Between OA and NK | Between OK and NK | |
| 3 | 28 (22) | 29 (20) | 5 (4) | .002 | 1.507 | 4.859 | 3.526 |
| 4 | 43 (34) | 40 (28) | 43 (37) | ||||
| 5 | 55 (44) | 73 (52) | 67 (56) | ||||
| Mean ± SD | 4.21 ± 0.79 | 4.31 ± 0.79 | 4.54 ± 0.58∗ | ||||
Data are demonstrated as frequency (percentage).
One-way analysis of variance following Tukey post hoc test was performed for statistical analysis.
A P < .05 with q > 3.327 was considered as significant.
Significantly higher than OA and OK cohorts.
1: agitated, 2: alert, 3: calm, 4: drowsy, and 5: sleep.
Sedation score had been evaluated one time by anesthesiologists.
OA cohort = children suspectable to preoperative ketamine and received apple juice only, OK cohort = children received preanesthetic oral ketamine.
Postoperative pain measurements.
| Cohorts | Comparison between cohorts | ||||||
| Visual analog scale score | OA | OK | NK | ||||
| Preanesthetic interventions | Apple juice | Oral ketamine | Nebulized ketamine | ||||
| Numbers of children | 126 | 142 | 115 | Between OA and OK | Between OA and NK | Between OK and NK | |
| 3 | 0 (0) | 0 (0) | 5 (4) | <.0001 | 3.664 | 6.744 | 3.359 |
| 4 | 42 (33) | 51 (36) | 49 (43) | ||||
| 5 | 41 (33) | 65 (46) | 49 (43) | ||||
| 6 | 29 (23) | 22 (15) | 11 (9) | ||||
| 7 | 12 (10) | 4 (3) | 1 (1) | ||||
| 8 | 2 (1) | 0 (0) | 0 (0) | ||||
| Mean ± SD | 5.13 ± 1.04 | 4.86 ± 0.79 | 4.60 ± 0.76∗ | ||||
Ordinal data are demonstrated as frequency (percentages).
One-way analysis of variance following Tukey post hoc test was performed for statistical analysis.
A P < .05 and q > 3.327 were considered as significant.
Significantly fewer than OA and OK cohorts.
0: absent pain, 10: maximum possible pain.
OA cohort = children suspectable to preoperative ketamine and received apple juice only, OK cohort = children received preanesthetic oral ketamine.
Figure 2Paracetamol infusion consumption for postoperative pain management. Data are demonstrated as mean ± standard deviation. One-way analysis of variance following the Tukey post hoc test was performed for statistical analysis. A P < .05 and q > 3.327 were considered as significant. ∗Significantly fewer than OA and OK cohorts. 10 mg/mL, 100 mL paracetamol infusion administered for postoperative pain management (maximum 2 infusions per day, and maximum for 3 days). OA cohort = children suspectable to preoperative ketamine and received apple juice only, OK cohort = children received preanesthetic oral ketamine.
Figure 3Total fentanyl consumption until discharge. Data are demonstrated as mean ± standard deviation. One-way analysis of variance following the Tukey post hoc test was performed for statistical analysis. A P < .05 and q > 3.327 were considered as significant. ∗Significantly fewer than OA and OK cohorts. #Significantly fewer than the OA cohort. When VAS score increased more than 3, 25 μG fentanyl injection was administered. OA cohort = children suspectable to preoperative ketamine and received apple juice only, OK cohort = children received preanesthetic oral ketamine.
Figure 4Postoperative nausea and vomiting management. Data are demonstrated as a mean ± standard deviation. One-way analysis of variance following the Tukey post hoc test was performed for statistical analysis. A P < .05 and q > 3.327 were considered as significant. #Significantly higher than OA and NK cohorts. ∗Significantly fewer than OK cohort. On the occasion of nausea and/or vomiting, 5 mL of oral ondansetron syrup (4 mg/ 5 mL) was given. NK cohort = children were preanesthetic nebulized with ketamine, OA cohort = children suspectable to preoperative ketamine and received apple juice only, OK cohort = children received preanesthetic oral ketamine.
Postoperative complications.
| Cohorts | Comparison between cohorts | ||||||
| Adverse effect | OA | OK | NK | ||||
| Preanesthetic interventions | Apple juice | Oral ketamine | Nebulized ketamine | ||||
| Numbers of children | 126 | 142 | 115 | Between OA and OK | Between OA and NK | Between OK and NK | |
| Agitation | 1 (1) | 2 (1) | 2 (2) | .806 | N/A | N/A | N/A |
| Gastrointestinal side effects | 1 (1) | 11 (8)∗ | 2 (2) | .004 | 4.326 | 0.558 | 3.647 |
| Nose irritation | 1 (1) | 2 (1) | 11 (10)∗ | .001 | 0.385 | 5.218 | 4.988 |
| Drowsiness | 1 (1) | 2 (1) | 7 (6)∗ | .019 | 0.448 | 3.664 | 3.329 |
| Dry mouth | 1 (1) | 2 (1) | 5 (4) | .122 | N/A | N/A | N/A |
| Laryngospasm | 1 (1) | 1 (1) | 2 (2) | .681 | N/A | N/A | N/A |
| Cough | 2 (2) | 3 (2) | 5 (4) | .366 | N/A | N/A | N/A |
| Hoarseness | 0 (0) | 0 (0) | 2 (2) | .096 | N/A | N/A | N/A |
| Double vision | 0 (0) | 1 (1) | 2 (2) | .309 | N/A | N/A | N/A |
| Skin inflammation/rash | 0 (0) | 2 (1) | 2 (2) | .361 | N/A | N/A | N/A |
| Loss of appetite | 0 (0) | 0 (0) | 1 (1) | .313 | N/A | N/A | N/A |
| Increase in salivation | 0 (0) | 0 (0) | 1 (1) | .313 | N/A | N/A | N/A |
| Pain when urinating | 0 (0) | 0 (0) | 1 (1) | .313 | N/A | N/A | N/A |
Data are demonstrated as frequency (percentages).
One-way analysis of variance following the Tukey post hoc test was performed for statistical analysis.
A P < .05 and q > 3.327 were considered as significant.
Significant adverse effect.
N/A = not applicable.